Dark

ERYP
Erytech Pharma S.A.
stock NASDAQ

Inactive

Jun 28, 2023

0.7800USD0.000%(0.0000)3,205

Pre-market

0.00USD-100.000%(-0.78)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 24, 2022

01:30AM EST ERYTECH AnnouncesPresentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer at ASCO GI GlobeNewswire Inc

Jan 12, 2022

01:55PM EST Erytech Pharma Receives Notice Of Allowance For Its U.S. Patent Application Titled 'ARGININE DEIMINASE ENCAPSULATED INSIDE ERYTHROCYTES AND THEIR USE IN TREATING CANCER AND ARGINASE-1 DEFICIENCY' Benzinga

Jan 10, 2022

12:00PM EST Monthly information related to total number of voting rights and GlobeNewswire Inc

Jan 3, 2022

04:05PM EST ERYTECH to Participate intheUpcoming January Virtual Investor Conferences GlobeNewswire Inc

Dec 14, 2021

01:30AM EST ERYTECH Announces $7.85 Million Registered Direct Offering GlobeNewswire Inc

Dec 13, 2021

04:13PM EST ERYTECH Highlights Presentation Of Results Of Expanded Access Program In Acute Lymphoblastic Leukemia At American Society Of Hematology, Acceptance Of 2 Abstracts At American Society Of Clinical Oncology Benzinga

04:05PM EST ERYTECH AnnouncesPresentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeting and Acceptance of Two Abstracts at ASCO GI GlobeNewswire Inc

Nov 30, 2021

04:47PM EST Erytech Pharma Shares Up 35% In Premarket Session; Co Announced Monday Co Secures U.S. Patent Titled 'Method of treating a mammal, including human, against cancer using methionine and asparagine depletion' Benzinga

04:47PM EST ERYTECH Shares Rise 35% Premarket After Company on Monday Announced US Patent Directed to Sequential Use of Methioninase & Asparaginase against Solid Tumors Benzinga

04:47PM EST ERYTECH Shares Up 35% In Premarket Session; Co Announced Monday Co Secures U.S. Patent Titled 'Method of treating a mammal, including human, against cancer using methionine and asparagine depletion' Benzinga

Nov 29, 2021

04:05PM EST ERYTECH Secures US Patent Directed to Sequential Use of Methioninase & Asparaginase against Solid Tumors GlobeNewswire Inc

Nov 15, 2021

04:05PM EST ERYTECH Provides Business and Financial Update for the Third Quarter of 2021 GlobeNewswire Inc

11:07AM EST Earnings Scheduled For November 15, 2021 Benzinga

01:30AM EST ERYTECH Announces Upcoming Poster Presentation at the 2021 American Society of Hematology Annual Meeting GlobeNewswire Inc

Nov 10, 2021

01:30AM EST ERYTECH AnnouncesPublication of aPaper on Red-Blood Cell Characterization in High Impact Peer ReviewedJournal GlobeNewswire Inc

Nov 9, 2021

02:00AM EST ERYTECH to Present at the 12th Annual Jefferies Global London Healthcare ConferenceIn-Person Dates: November 16th-17thVirtual Dates: November 18th-19th GlobeNewswire Inc

Nov 5, 2021

01:22PM EDT Monthly information related to total number of voting rights and shares composing the share capital October30, 2021. GlobeNewswire Inc

Oct 25, 2021

02:31PM EDT Mid-Afternoon Market Update: Nasdaq Jumps 150 Points; Bakkt Holdings Shares Spike Higher Benzinga

12:12PM EDT Mid-Day Market Update: Crude Oil Rises Over 1%; ERYTECH Pharma Shares Plummet Benzinga

10:17AM EDT Mid-Morning Market Update: Markets Edge Higher; Kimberly Clark Cuts FY21 Forecast Benzinga

07:00AM EDT The following are some of the stocks making big moves in Monday's pre-market trading (as of 06.25 A.M. EDT). RTTNews

01:00AM EDT ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Second-line Advanced Pancreatic Cancer GlobeNewswire Inc

Oct 7, 2021

12:00PM EDT Monthly information related to total number of voting rights and GlobeNewswire Inc

Oct 4, 2021

04:09PM EDT ERYTECH Announces Maximum Tolerated Dose Declared In A Phase 1 Investigator Sponsored Trial Of Eryaspase In First-Line Pancreatic Cancer Benzinga

Sep 28, 2021

04:05PM EDT ERYTECH to ParticipateintheHealthTech Innovation Days (HTID) by France Biotech GlobeNewswire Inc

Sep 22, 2021

12:32PM EDT ERYTECH Announces Availability Of Half-Year Financial Report 2021 On Co's Website Benzinga

12:30PM EDT ERYTECH Announces the Availabilityof its Half-Year Financial Report 2021 GlobeNewswire Inc

Sep 21, 2021

12:57PM EDT Erytech Pharma F-3 Filing Shows Registration For $300M Common Stock, Warrants Shelf Offering Benzinga

Sep 20, 2021

04:09PM EDT Erytech Reports First Half Net Loss 28M, Down Benzinga

04:05PM EDT ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2021 GlobeNewswire Inc

03:35AM EDT Earnings Scheduled For September 20, 2021 Benzinga

Sep 15, 2021

04:05PM EDT ERYTECH to Host on September 21, 2021 Second Quarter 2021 conference call and Business Update GlobeNewswire Inc

Sep 6, 2021

04:05PM EDT ERYTECH to Present at the H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire Inc

Sep 3, 2021

12:00PM EDT Monthly information related to total number of voting rights and GlobeNewswire Inc

Aug 30, 2021

04:05PM EDT ERYTECH to Participate in the Citi 16th Annual BioPharma Conference GlobeNewswire Inc

Aug 24, 2021

04:30PM EDT ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic Cancer GlobeNewswire Inc

Jul 30, 2021

03:29PM EDT Mid-Afternoon Market Update: Nasdaq Falls Over 100 Points; Erytech Pharma Shares Spike Higher Benzinga

11:58AM EDT Mid-Day Market Update: Atlassian Surges Following Strong Q4 Results; Pinterest Shares Slide Benzinga

10:19AM EDT Mid-Morning Market Update: Markets Down; Procter & Gamble Beats Q4 Views Benzinga

10:13AM EDT Shares of Erytech Pharma S.A. (ERYP) more than doubled on the news that the U.S. FDA granted the French clinical-stage stage biopharmaceutical company's acute lymphocytic leukemia (ALL) treatment Fast Track Designation. RTTNews

08:53AM EDT Benzinga Pro's Top 5 Stocks To Watch For Friday, Jul. 30, 2021: SAVA, PINS, ERYP, LTRN, UAA Benzinga

07:54AM EDT The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs Benzinga

Jul 29, 2021

04:07PM EDT ERYTECH Announced It Eryaspase Has Received U.S. FDA Fast Track Designation For The Treatment Of Acute Lymphocytic Leukemia Benzinga

08:18AM EDT The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs Benzinga

Jul 27, 2021

01:30AM EDT ERYTECH to Participate in the BTIG Virtual Biotechnology Conference GlobeNewswire Inc

Jul 22, 2021

11:34AM EDT The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, Absci IPO Benzinga

Jul 21, 2021

04:05PM EDT ERYTECH Confirms Plans To Submit BLAforEryaspase in Hypersensitive ALL Patients GlobeNewswire Inc

07:52AM EDT The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay Benzinga

Jul 16, 2021

07:37AM EDT The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study Benzinga

Jul 15, 2021

08:08AM EDT The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs Benzinga

Jul 6, 2021

12:00PM EDT Monthly information related to total number of voting rights and GlobeNewswire Inc

Jun 25, 2021

04:30PM EDT Report - Erytechs Combined GlobeNewswire Inc

Jun 24, 2021

08:12AM EDT The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO Benzinga

Jun 23, 2021

10:34AM EDT Erytech Pharma Granted European Patent Titled 'METHIONINE AND ASPARAGINE DEPLETION FOR USE IN TREATING A CANCER' Benzinga

07:35AM EDT The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway Benzinga

Jun 22, 2021

08:12AM EDT The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal Benzinga

Jun 7, 2021

12:00PM EDT Monthly information related to total number of voting rights and shares composing the share capital May 31, 2021. GlobeNewswire Inc

May 26, 2021

04:30PM EDT ERYTECH to Participate in Upcoming Virtual Investor Conferences in June GlobeNewswire Inc

May 25, 2021

04:00PM EDT Erytechs Combined Shareholders GlobeNewswire Inc

May 7, 2021

12:00PM EDT Monthly information related to total number of voting rights and GlobeNewswire Inc

Apr 29, 2021

02:30AM EDT ERYTECH Announces $30.0 Million Registered Direct Offering GlobeNewswire Inc

Apr 20, 2021

08:07AM EDT The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex Benzinga

01:30AM EDT ERYTECH Requesteda Pre-BLA Meeting with the FDA to Discuss Path to Approval in ALL GlobeNewswire Inc

Apr 19, 2021

05:38AM EDT ERYTECH Announced Completion of First Cohort in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer Benzinga

Apr 7, 2021

04:30PM EDT ERYTECH to Participate in Upcoming Virtual Investor Conferences in April GlobeNewswire Inc

12:00PM EDT Monthly information related to total number of voting rights and GlobeNewswire Inc

Mar 9, 2021

04:30PM EST ERYTECH Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F GlobeNewswire Inc

Mar 8, 2021

04:30PM EST ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020 GlobeNewswire Inc

04:05AM EST Earnings Scheduled For March 8, 2021 Benzinga

Mar 5, 2021

12:00PM EST Monthly information related to total number of voting rights and GlobeNewswire Inc

Mar 4, 2021

04:31PM EST ERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and Business Update GlobeNewswire Inc

Feb 24, 2021

04:30PM EST ERYTECH to Participate in Upcoming Virtual Investor Conferences in March GlobeNewswire Inc

Feb 10, 2021

04:30PM EST ERYTECH to Present at the 2021 BIO CEO & Investor Conference GlobeNewswire Inc

Feb 9, 2021

01:47AM EST ATHE Gets Funded For Parkinson's Research, No Safety RTTNews

Feb 8, 2021

01:30AM EST ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis GlobeNewswire Inc

Feb 4, 2021

01:00PM EST Monthly information related to total number of voting rights and GlobeNewswire Inc

Jan 25, 2021

04:30PM EST ERYTECH Highlights 2021 Milestones and Provides Update on Cash Position GlobeNewswire Inc

Jan 14, 2021

04:32PM EST ERYTECH Announces First Patient Enrolled in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer Benzinga

Jan 6, 2021

04:30PM EST ERYTECH to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference GlobeNewswire Inc

Jan 4, 2021

02:00AM EST ERYTECH to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event GlobeNewswire Inc

Dec 14, 2020

04:31PM EST ERYTECH Completes Enrollment In TRYbeCA-1 Phase 3 Trial In Second-Line Pancreatic Cancer Benzinga

04:30PM EST -- A total of 510 patients enrolled -- Events required to trigger interim superiority analysis accrued -- Interim superiority analysis expected in Q1 2021; final analysis in Q4 2021 GlobeNewswire Inc

Dec 10, 2020

04:30PM EST ERYTECH to Present at the JMP SecuritiesHematology Summit GlobeNewswire Inc

Dec 7, 2020

02:00AM EST ERYTECH Announces Positive Results from Eryaspase Phase 2 Trial in GlobeNewswire Inc

Dec 6, 2020

08:41AM EST Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace Benzinga

Dec 3, 2020

04:30PM EST ERYTECH Pharma (Nasdaq & Euronext: ERYP),a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announcesa webcast scheduled for investors to discuss the results from the NOPHO sponsored Phase 2 trial of eryaspase in ALL patients. GlobeNewswire Inc

Nov 5, 2020

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

02:00AM EST -- Oral presentation to discuss findings from the Nordic Society of PaediatricHaematology and Oncology(NOPHO)-sponsored Phase 2trial that confirm the potential of eryaspase as a treatment option for ALL -- Second abstract of new analysis supporting population pharmacokinetics of eryaspase in patients with ALL or pancreatic adenocarcinoma will also be presented GlobeNewswire Inc

Nov 2, 2020

03:19AM EST -- Approvals received from Bpifrance and SocitGnralefor a total of EUR 10 million in non-dilutive financing in the form of a State-Guaranteed Loan (PGE Loan) -- Proceeds expected to extend Companys cash horizon to end of 2021 GlobeNewswire Inc

Oct 26, 2020

05:30PM EDT ERYTECH Appoints Stewart Craig as Chief Technical Officer GlobeNewswire Inc

Sep 21, 2020

04:46PM EDT ERYTECH Provides Business Update: Says Had Cash And Equivalents Of $51M At End Of Jun. Benzinga

04:45PM EDT -- TRYbeCA-1 Phase 3 trial in second-line metastatic pancreatic cancer:More than 90% of the planned 500 patients enrolled Fast-Track designation granted by U.S. FDAInterim superiority analysis expected in Q1 2021; final analysis in 2H of 2021 GlobeNewswire Inc

04:33PM EDT ERYTECH Reports Establishment Of A Financing Facility With Implementation Of At-The-Market Program On Nasdaq for $30M Benzinga

04:30PM EDT ERYTECH establishes a financing facility with the implementation GlobeNewswire Inc

04:09AM EDT Earnings Scheduled For September 21, 2020 Benzinga

Sep 16, 2020

04:30PM EDT ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its second quarter 2020 conference call and webcast on Tuesday, September 22, 2020, at 2:30 PM CEST/8:30 AM EST to discuss operational highlights. GlobeNewswire Inc

Sep 14, 2020

04:33PM EDT ERYTECH Announces The Hosting Of KOL Event As The TRYbeCA-1 Phase 3 Trial In Second-Line Pancreatic Cancer Nears Complete Enrollment Benzinga

04:30PM EDT -- More than 450 of the planned ~500 patients enrolled -- Interim superiority analysis expected around year-end 2020 -- Call with KOL Dr. Manuel Hidalgo on September 29, 2020 at 10:00 am ET GlobeNewswire Inc

12:00PM EDT Monthly information related to total number of voting rights and GlobeNewswire Inc

document.getElementById("l6c1CV").onerror = function(){this.style.display='none';}; .dark-mode .L7WpNP{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .L7WpNP{ color: #333333; background-color: white; border: 2px solid #333333; }ERYPErytech Pharma S.A.stock NASDAQ

ERYP
Erytech Pharma S.A.
stock NASDAQ